Clorox Analysts Slash Their Forecasts After Downbeat Results

Clorox Company CLX posted weaker-than-expected third-quarter results after Monday’s closing bell.

Clorox reported quarterly earnings of $1.45 per share, which missed the analyst consensus estimate of $1.57. Quarterly revenue came in at $1.67 billion, which missed the analyst consensus estimate of $1.73 billion and is down from revenue of $1.81 billion from the same period last year.

“In the third quarter, heightened macroeconomic uncertainties drove changes in shopping behaviors, resulting in temporary category slowdowns and lower sales. We expect these slowdowns to persist in the fourth quarter, as reflected in our updated outlook,” said CEO Linda Rendle.

Clorox affirmed its fiscal 2025 adjusted EPS guidance of $6.95 to $7.35 per share, versus the $7.12 analyst estimate. The company narrowed its fiscal year revenue outlook from a range of $7.02 billion to $7.24 billion to a range of $7.02 billion to $7.09 billion, below the $7.1 billion estimate.

Clorox shares fell 0.5% to close at $138.39 on Monday.

These analysts made changes to their price targets on Clorox following earnings announcement.

• JP Morgan analyst Andrea Teixeira maintained Clorox with a Neutral and lowered the price target from $151 to $144.
• Wells Fargo analyst Chris Carey maintained Clorox with an Equal-Weight rating and lowered the price target from $145 to $142.

Considering buying CLX stock? Here’s what analysts think: